跳至主要内容
临床试验/NCT04987268
NCT04987268已完成不适用

Clonal Hematopoiesis of Indeterminate Potential and Residual Cardiovascular Event Tendency After Smoking Cessation

Shenyang Northern Hospital1 个研究点 分布在 1 个国家目标入组 1,029 人开始时间: 2021年8月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,029
试验地点
1
主要终点
prevalence of CHIP mutations

研究概览

简要总结

In order to identify the association between clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular risks after smoking cessation, this study intends to recruit ACS patients undergoing complete revascularization and perform whole-exome sequencing for enrolled patients to identify the prevalence of CHIP mutations. After 1-year follow-up, the relationship of presence of CHIP mutations and the occurrence of MACCEs will be explored, irrespective of smoking cessation or not. CHIP may be a potential risk factor of poor prognosis of ACS.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • 1. In-patients with acute coronary syndrome to undergo PCI
  • Complete revascularization during the index hospitalization
  • Written informed consent

排除标准

  • 1. Periprocedural complications (coronary artery dissection, perforation, myocardial infarction, stroke, death)
  • Planned coronary revascularization at discharge
  • Patients with severe chronic disease (uremia, liver cirrhosis, COPD (chronic obstructive pulmonary disease)
  • Abnormal blood counts caused by hematological diseases
  • Diagnosed malignancy

结局指标

主要结局

prevalence of CHIP mutations

时间窗: 24 hours

Whole-exome sequencing is performed to detect the presence of CHIP mutations

次要结局

  • MACCE(1 year)

研究者

发起方
Shenyang Northern Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Han Yaling

Director of cardiology, Shenyang Northern Hospital

Shenyang Northern Hospital

研究点 (1)

Loading locations...

相似试验

CHIP and Residual Cardiovascular Event Tendency... | 临床试验